Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment

J Am Acad Dermatol. 2020 Jul;83(1):e77-e79. doi: 10.1016/j.jaad.2020.04.136. Epub 2020 May 1.

Authors

Maria Vastarella¹, Angela Patrì², Maria Carmela Annunziata¹, Mariateresa Cantelli¹, Paola Nappa¹, Marco Tasso³, Luisa Costa³, Francesco Caso³, Gabriella Fabbrocini¹

Affiliations

¹ Sections of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
² Sections of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy. Electronic address: patriangela.ap@gmail.com.
³ Section of Rheumatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Adolescent
Adult
Aged
Arthritis, Rheumatoid / drug therapy*
Betacoronavirus / pathogenicity*
COVID-19
Chronic Disease / drug therapy
Coronavirus Infections / epidemiology
Coronavirus Infections / prevention & control*
Coronavirus Infections / virology
Female
Humans
Hydroxychloroquine / administration & dosage*
Hydroxychloroquine / adverse effects
Italy / epidemiology
Male
Middle Aged
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / virology
Retrospective Studies
SARS-CoV-2
Skin Diseases / drug therapy*
Surveys and Questionnaires / statistics & numerical data
Telephone / statistics & numerical data
Young Adult

Substances

Hydroxychloroquine